These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1135333)

  • 1. [Course of treatment in schizophrenia as related to the appearance of affective disorders].
    Jarosyzyński J; Rzewuska-Szatkowska M; Skowrońska J; Tarczyńska K
    Psychiatr Pol; 1975; 09(2):113-20. PubMed ID: 1135333
    [No Abstract]   [Full Text] [Related]  

  • 2. [Affectivity of patients with paranoid schizophrenia].
    Bokov SN
    Vrach Delo; 1988 Apr; (4):108-9. PubMed ID: 3400206
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical picture and treatment of torpid schizophrenia with senestopathic and depressive disorders].
    Prokopochkin AA; Shapkin IuA; Shumskiĭ NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(5):82-7. PubMed ID: 3414279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A method of diagnosing disorders of purposeful activity].
    Moskvin VA
    Vrach Delo; 1987 Apr; (4):103-6. PubMed ID: 3617622
    [No Abstract]   [Full Text] [Related]  

  • 5. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term therapy of affective disorders and schizophrenia.
    Kielholz P
    Pharmakopsychiatr Neuropsychopharmakol; 1976 May; 9(3):93. PubMed ID: 981329
    [No Abstract]   [Full Text] [Related]  

  • 7. Affective reactivity of cognitive functioning and family history in schizophrenia.
    Docherty NM; Grosh ES; Wexler BE
    Biol Psychiatry; 1996 Jan; 39(1):59-64. PubMed ID: 8719127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of psychotropic drugs in the insidious deconstruction of the Kraepelinian dichotomy.
    Vinar O
    Psychiatr Danub; 2007 Dec; 19(4):354-8. PubMed ID: 18000488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithm for the treatment of negative symptoms in chronic schizophrenia.
    Tsutsumi T; Uchimura H
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S15-7. PubMed ID: 10560892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The treatment of negative symptoms: pharmacological and methodological issues.
    Carpenter WT
    Br J Psychiatry Suppl; 1996 May; (29):17-22. PubMed ID: 8733819
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychotropic drugs and mental illness.
    WHO Chron; 1976 Oct; 30(10):420-4. PubMed ID: 969489
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthetic delta-9-tetrahydrocannabinol (dronabinol) can improve the symptoms of schizophrenia.
    Schwarcz G; Karajgi B; McCarthy R
    J Clin Psychopharmacol; 2009 Jun; 29(3):255-8. PubMed ID: 19440079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and social determinants of psychotropic drug prescription for schizophrenia outpatients in China.
    Xiang YT; Weng YZ; Leung CM; Tang WK; Ungvari GS; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):756-60. PubMed ID: 17289236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response.
    Jäger M; Riedel M; Schmauss M; Pfeiffer H; Laux G; Naber D; Gaebel W; Huff W; Schmidt LG; Heuser I; Buchkremer G; Kühn KU; Rüther E; Hoff P; Gastpar M; Bottlender R; Strauss A; Möller HJ
    Psychiatry Res; 2008 Apr; 158(3):297-305. PubMed ID: 18280582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of neuroleptics and other psychotropic drugs on negative symptoms in schizophrenia.
    Meltzer HY; Sommers AA; Luchins DJ
    J Clin Psychopharmacol; 1986 Dec; 6(6):329-38. PubMed ID: 2879856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Compliance in the treatment of schizophrenia -- results of an expert survey in Saxony and Saxony-Anhalt].
    Giessler A; Born A; Helm H; Puschner B; Becker T
    Psychiatr Prax; 2005 Oct; 32(7):349-57. PubMed ID: 16220419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case control study on psychopharmacotherapy before suicide committed by 61 psychiatric inpatients.
    Gaertner I; Gilot C; Heidrich P; Gaertner HJ
    Pharmacopsychiatry; 2002 Mar; 35(2):37-43. PubMed ID: 11951144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant therapeutic effects of galantamine on apathy in a schizophrenia patient.
    Arnold DS; Rosse RB; Dickinson D; Benham R; Deutsch SI; Nelson MW
    J Clin Psychiatry; 2004 Dec; 65(12):1723-4. PubMed ID: 15641883
    [No Abstract]   [Full Text] [Related]  

  • 19. [New drug therapies].
    Olié JP; Baylé FJ
    Encephale; 1996 Oct; 22 Spec No 3():63-71; discussion 76. PubMed ID: 8954280
    [No Abstract]   [Full Text] [Related]  

  • 20. Prodromal symptoms and prevention of relapse in schizophrenia.
    Herz M
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):22-5. PubMed ID: 2865253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.